NeoGenomics 2024年第四季度调整后每股收益$0.04,超出预期的$0.03,销售额为$1.72亿,不及预期的$1.7318亿

财报速递
18 Feb
NeoGenomics(纳斯达克代码:NEO)报告季度每股收益为0.04美元,高于分析师一致预期的0.03美元,超出33.33%。这比去年同期的每股收益增加了33.33%。公司报告季度销售额为1.72亿美元,低于分析师一致预期的1.7318亿美元,低出0.68%。这比去年同期的销售额1.5555亿美元增加了10.57%。

以上内容来自Benzinga Earnings专栏,原文如下:

NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $172.00 million which missed the analyst consensus estimate of $173.18 million by 0.68 percent. This is a 10.57 percent increase over sales of $155.55 million the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10